PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Association of psychiatric disorders with mortality among patients with COVID-19

2021-01-27
(Press-News.org) What The Study Did: 
In this observational study of about 7,300 adults with laboratory-confirmed COVID-19 in a New York health system, a schizophrenia spectrum diagnosis was associated with an increased risk of death after adjusting for demographic and medical risk factors. Mood and anxiety disorders weren't associated with increased risk of mortality.

Authors: 
Donald C. Goff, M.D., of New York University Langone Medical Center in New York, is the corresponding author.

To access the embargoed study:
Visit our For The Media website at this link
https://media.jamanetwork.com/

(doi:10.1001/jamapsychiatry.2020.4442)

Editor's Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

INFORMATION:

Media advisory:
The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article 
This link will be live at the embargo time
https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2020.4442?guestAccessKey=6c5fe1ee-05bb-4072-8f34-430d3a286cd1&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=012721



ELSE PRESS RELEASES FROM THIS DATE:

Examining oncology clinical trials launched before, during COVID-19 pandemic

2021-01-27
What The Study Did: Researchers evaluated the association between the pandemic and clinical research and development by studying the initiation of oncology clinical trials over time. Authors: Elizabeth B. Lamont, M.D., M.S., M.MSc., of Acorn AI by Medidata, a Dassault Systèmes Company, in Boston, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2020.36353) Editor's Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial ...

New findings on devonian 'platypus fish' cast light on evolution of modern jawed vertebrates

2021-01-27
New findings on the brain and inner ear cavity of a 400-million-year-old platypus-like fish cast light on the evolution of modern jawed vertebrates, according to a study led by Dr. ZHU Youan and Dr. LU Jing from the Institute of Vertebrate Paleontology and Paleoanthropology (IVPP) of the Chinese Academy of Sciences. The study was published in Current Biology on Jan 27. Back in 1960s, Paleontologist Dr. Gavin C. Young found several fossils of a long-beaked fish, a type of placoderm, in the Burrinjuck limestones in Australia. He named the fish Brindabellaspis stensioi, and other people jokingly dubbed it "platypus fish" because of its long ...

How does the immune system keep tabs on the brain?

How does the immune system keep tabs on the brain?
2021-01-27
Alzheimer's disease, multiple sclerosis, autism, schizophrenia and many other neurological and psychiatric conditions have been linked to inflammation in the brain. There's growing evidence that immune cells and molecules play a key role in normal brain development and function as well. But at the core of the burgeoning field of neuroimmunology lies a mystery: How does the immune system even know what's happening in the brain? Generations of students have been taught that the brain is immunoprivileged, meaning the immune system largely steers clear of it. Now, researchers at Washington University School of Medicine in St. Louis believe they have figured out how the immune system keeps tabs on what's going on in the brain. Immune ...

A new study reveals an "Achilles heel" of cancer cells

A new study reveals an Achilles heel of cancer cells
2021-01-27
What makes cancer cells different from ordinary cells in our bodies? Can these differences be used to strike at them and paralyze their activity? This basic question has bothered cancer researchers since the mid-19th century. The search for unique characteristics of cancer cells is a building block of modern cancer research. A new study led by researchers from Tel Aviv University shows, for the first time, how an abnormal number of chromosomes (aneuploidy) -- a unique characteristic of cancer cells that researchers have known about for decades -- could become a weak ...

Key switchgrass genes identified, which could mean better biofuels ahead

Key switchgrass genes identified, which could mean better biofuels ahead
2021-01-27
Biologists believe they are one step closer to a long-held goal of making a cheap, widely available plant a source for energy and fuel, meaning one of the next big weapons in the battle against climate change may be able to trace its roots to the side of a Texas highway. Researchers at The University of Texas at Austin, HudsonAlpha Institute for Biotechnology, the U.S. Department of Energy (DOE) and other institutions have published a complex genome analysis of switchgrass, a promising biofuel crop. The team tied different genes to better performance in varying climates across North America, which now gives scientists a road map for breeding ...

Antibody highs and lows in survivors of Ebola

Antibody highs and lows in survivors of Ebola
2021-01-27
A high proportion of survivors of Ebola experienced a resurgence in antibody levels nearly a year after recovery, a new University of Liverpool study has found. Published today in Nature, the finding hints that hidden reservoirs of virus could exist long after symptoms ease and has implications for monitoring programmes and vaccine strategies. When a person is infected with Ebola virus, their body produces antibodies to fight the disease. Antibody concentrations peak and then decline slowly over time, providing the body with some degree of immune protection ...

Scientists discover a new promising target for diabetes treatment

Scientists discover a new promising target for diabetes treatment
2021-01-27
Researchers have discovered a novel and druggable insulin inhibitory receptor, named inceptor. The latest study from Helmholtz Zentrum Muenchen, the Technical University of Munich and the German Center for Diabetes Research is a significant milestone for diabetes research as the scientific community celebrates 100 years of insulin and 50 years of insulin receptor discovery. The blocking of inceptor function leads to an increased sensitisation of the insulin signaling pathway in pancreatic beta cells. This might allow protection and regeneration of beta cells for diabetes remission. Diabetes mellitus is a complex disease characterized by the loss or dysfunction of insulin-producing beta cells in the islets of Langerhans, ...

Well connected through amides

2021-01-27
Linking molecular components through amide bonds is one of the most important reactions in research and the chemical industry. In the journal Angewandte Chemie, scientists have now introduced a new type of reaction for making amide bonds. Called an ASHA ligation, this reaction is fast, efficient, works under mild aqueous conditions, and is broadly applicable. Amide bonds are the bond between a carbonyl carbon (C=O) and an organic nitrogen atom. It is amide bonds that link individual amino acids together into proteins and bind monomers into polyamide plastics like perlon ...

Findings may help close door on COVID-19

Findings may help close door on COVID-19
2021-01-27
Researchers at Vanderbilt University Medical Center (VUMC) and the University of Texas Medical Branch (UTMB) at Galveston have discovered what may be the Achilles' heel of the coronavirus, a finding that may help close the door on COVID-19 and possibly head off future pandemics. The coronavirus is an RNA virus that has, in its enzymatic toolkit, a "proofreading" exoribonuclease, called nsp14-ExoN, which can correct errors in the RNA sequence that occur during replication, when copies of the virus are generated. Using cutting-edge technologies and novel bioinformatics approaches, the researchers discovered that this ExoN also regulates the rate of recombination, the ability of the coronavirus ...

Getting to net zero -- and even net negative -- is surprisingly feasible, and affordable

Getting to net zero -- and even net negative -- is surprisingly feasible, and affordable
2021-01-27
Reaching zero net emissions of carbon dioxide from energy and industry by 2050 can be accomplished by rebuilding U.S. energy infrastructure to run primarily on renewable energy, at a net cost of about $1 per person per day, according to new research published by the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab), the University of San Francisco (USF), and the consulting firm Evolved Energy Research. The researchers created a detailed model of the entire U.S. energy and industrial system to produce the first detailed, peer-reviewed study of how to achieve carbon-neutrality by 2050. According to the Intergovernmental Panel on Climate Change (IPCC), the world must reach zero net CO2 ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Association of psychiatric disorders with mortality among patients with COVID-19